Morphea after silicone gel breast implantation for cosmetic reasons in an HLA-B8, DR3-positive woman

International Archives of Allergy and Immunology

Volumn 112, Issue 1, 1997, Pages 93-95

  Di Lorenzo, Gabriele ^a   Mansueto, Pasquale ^a   Melluso, Marcello ^a   Sangiorgi, Giuseppe Barbagallo ^a   Cigna, Diego ^b   Candore, Giuseppina ^b   Caruso, Calogero ^b  

^a Istituto di Medicina Interna e Geriatria e   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

HLA B8, DR3; Morphea; Silicone implant

Indexed keywords

HLA B8 ANTIGEN; HLA DR ANTIGEN; SILICONE;

ADULT; ARTICLE; AUTOIMMUNITY; BREAST ENDOPROSTHESIS; BREAST RECONSTRUCTION; CASE REPORT; ESTHETIC SURGERY; FEMALE; HUMAN; MORPHEA; PRIORITY JOURNAL; SCLERODERMA; SILICONE PROSTHESIS;

EID: 0031060697     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237437     Document Type: Article

References (21)

1. Bridges AJ: Silicone implant controversy continues, Lancet 1994;344:1451-1452.
2. Bricout N, De Roquancourt A, Saouma S, Servant JM, Banzet P: Risques locaux et généraux des implants de silicone, Chirurgie 1988; 114: 538-544.
3. Gabriel SE, O’Fallow WM, Kurland LT, Beard CM, Woods JE, Melton J: Risk of connective tissue diseases and other disorders after breast implantation, N Engl J Med 1994;330:1697-1702.
4. Janhauskas S: Scleroderma after silicone augmentation mammaplasty: Is there a causative relationship? Plast ReconstrSurg 1989;83:198.
5. Lazar AP, Lazar P: Localized morphea after silicone gel breast implantation: More evidence for a causc-and-cffcct relationship, Arch Dermatol 1991;127:263.
6. Spicra U, Scleroderma after silicone augmentation mammoplasty, JAMA 1988:260:236-238.
7. Rose NR, Potter M: The silicone controversy: Towards a resolution, Immunol Today 1995; 16: 459-460.
8. Modica MA, Colucci AT, Candore G, Caruso C: The HLA-B8.DR3 haplotype and immune response in healthy infjects, Immunol Infect Dis 1993;3:119-127.
9. Love LA, Weiner SR, Vasav FE, Crofford LJ, Oddis CV, Starr MR, Bridges AJ, Targoff N, Gurley RC, Miller FW: Clinical and immunoge-netic features of women who develop myositis after silicone implants (abstract), Arthritis Rheum 1992;35:S46.
10. Young VL, Nemecek JR, Schwartz BD, Phelan DL, Watson Schorr M: HLA typing in women with breast implants, Plast Reconstr Surg 1995; 96:1497-1519.
11. Morse JH, Fotino M, Zhang Y, Flaster ER, Peebles CL, Spicra H: Position 26 of the first domain of the HI, A-DQB1 allele in post-siliconc implant scleroderma, J Rheumatol 1995:22: 1872-1875.
12. Candore G, Cigna D, Todaro M, De Maria R, Stassi G, Giordano C, Caruso C: T cell activation in HLA-B8.DR3 positive individuals: Early antigen expression defect in vitro, Hum Immunol 1995;42:289-294.
13. Candore G, Cigna D, Gcrvasi F, Colucci AT, Modica MA, Caruso C: In vitro cytokine production by HLA-B8.DR3 positive infjects, Autoimmunity 1994;18:121-132.
14. Lio D, D’Anna C, Gcrvasi F, Cigna D, Modica MA, Candore G, Caruso C: In vitro impairment of interleukin-5 production in HLA-B8.DR3-positive individuals, Implications for immunoglobulin A synthesis dysfunction, Hum Immunol 1995;44:170-174.
15. Peterson LS, Nelson AM, Su WPD: Classification of morphea (localized scleroderma), Mayo ClinProc 1995;70:1068-1076.
16. Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL: Harrison’s Princi-plesof Internal Medicine, New York, McGraw-Hill, 1995.
17. Kuwana M, Kaburaki J, Okano Y, Inoko H, Tsuji K: The HLL-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma), J Clin Invest 1993;92:1296-1301.
18. Luderschmidt C, Scholz S, Mehlaff E, König G, Albert E: Association of progressive systemic scleroderma to several HLA-B and HLA-DR alleles, Arch Dermatol 1987;123:1188-1191.
19. Black CM, Welsh KI: Genetics of scleroderma, Clin Dermatol 1994;12:337-347.
20. Black C, Pereira S, McWhirtcr A, Welsh K, Laurent R: Genetic susceptibility to sclero-dcrma-likc syndrome in symptomatic and asymptomatic workers exposed to vinyl chloride, J Rheumatol 1986;13:1059-1062.
21. Signal DP, Reid B, Green D, D’Souza M, Bensen WG, Buchaman WW: Polymorphism of major histompatibility complex extended ha-plotypes bearing HLA-DR3 in patients with rheumatoid arthritis with gold induced trombo-cytopenia or proteinuria, Ann Rheum Dis 1990; 49:582-586.